Company: SUPN
Filing Date: 2025-11-04
Form Type: 8-K
Source: 0001356576-25-000068
Chunk: 0

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-11-04
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02 Results of Operations and Financial Condition.

On November 4, 2025, Supernus Pharmaceuticals, Inc. (“ Supernus” or the “ Company”) issued a press release regarding its financial results for the third quarter September 30, 2025. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

As previously announced, Supernus is hosting a conference call at 4:30 p. m. Eastern Time on Tuesday, November 4, 2025, to present the business and financial results. A live webcast is available at www. supernus. com. The webcast will be archived on the Company’s website for 60 days following the live call.

Item 7.01 Regulation FD Disclosure.